Yukon Metals Corp press release

SHAREHOLDER ALERT: MP CABA VRT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

2022-04-11

CSE - Canadian National Stock Exchange · Gold · Copper · Molybdenum · Silver · Lead · Zinc · Barium · Cadmium · Tin · Antimony · Arsenic · Cobalt · Nickel · Iron · Selenium · Tellurium · Scandium · Bismuth · Platinum · Lanthanum · Yttrium · Rare Earth Elements · Canada

NEW YORK, NY / ACCESSWIRE / April 11, 2022 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

MP Materials Corp. f/k/a Fortress Value Acquisition Corp.(NYSE:MP)

If you suffered a loss, contact us at:https://www.wongesq.com/pslra-1/mp-materials-corp-f-k-a-fortress-value-acquisition-corp-loss-submission-form?prid=25827&wire=1 Lead Plaintiff Deadline: April 25, 2022 Class Period: May 1, 2020 - February 2, 2022

Allegations against MP include that: (i) Fortress Value Acquisition Corp. ("FVAC") had overstated its due diligence efforts and expertise with respect to identifying target companies to acquire; (ii) FVAC performed inadequate due diligence into Legacy MP Materials prior to the business combination, or else ignored significant red flags regarding, inter alia, Legacy MP Materials' management, compliance policies, and Mountain Pass's profitability; (iii) as a result, the Company's future business and financial prospects post-business combination were overstated; (iv) MP Materials engaged in an abusive transfer price manipulation scheme with a related party in the People's Republic of China to artificially inflate the Company's profits; (v) MP Materials' ore at the Mountain Pass Rare Earth Mine and Processing Facility was not economically viable to harvest for rare earth metals; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times.

Cabaletta Bio, Inc.(NASDAQ:CABA)

If you suffered a loss, contact us at:https://www.wongesq.com/pslra-1/cabaletta-bio-inc-loss-submission-form?prid=25827&wire=1 Lead Plaintiff Deadline: April 29, 2022 This lawsuit is on behalf of persons and entities that purchased or otherwise acquired: (a) Cabaletta common stock pursuant and/or traceable to documents issued in connection with the Company's initial public offering conducted on or about October 24, 2019; and/or (b) Cabaletta securities between October 24, 2019 and December 13, 2021, both dates inclusive.

Allegations against CABA include that: (i) top-line data of the Phase 1 Clinical Trial indicated that Cabaletta's lead product candidate, DSG3-CAART, had, among other things, worsened certain participants' disease activity scores and necessitated additional systemic medication to improve disease activity after DSG3-CAART infusion; (ii) accordingly, DSG3-CAART was not as effective as the Company had represented to investors; (iii) therefore, the Company had overstated DSG3-CAART's clinical and/or commercial prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Vertiv Holdings Co(NYSE:VRT)

If you suffered a loss, contact us at:https://www.wongesq.com/pslra-1/vertiv-holdings-co-loss-submission-form?prid=25827&wire=1 Lead Plaintiff Deadline: May 23, 2022 Class Period: April 28, 2021 - February 23, 2022

Allegations against VRT include that: (1) the Company could not adequately respond to supply chain issues and inflation by increasing its prices; (2) as a result of the increasing costs, Vertiv's earnings would be adversely impacted; and (3) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.comor by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

View source version on accesswire.com: https://www.accesswire.com/697002/SHAREHOLDER-ALERT-MP-CABA-VRT-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines